Director of Research, Minneapolis Heart Institute Foundation
Cardiology
Dr. Timothy D. Henry, MD
|
|
Give Review
Timothy Henry practices Cardiology. He attended University of California San Francisco School of Medicine. University of California San Francisco School of Medicine is a one of the best medicals schools. University of California San Francisco School of Medicine is ranked 3/3 in Research/PrimaryCare. He has 4 awards "America's Top Doctors", "CMS Meaningful Use Stage 1 Certification", "Super Doctor" and "Fellow (FACC)". Doctor Timothy D. Henry, MD has written publications. He has 98 publications published with PubMed. The lastest paper is: 'Response to Letter Regarding Article, "Proton Pump Inhibitors, Platelet Reactivity, and Cardiovascular Outcomes After Drug-Eluting Stents in Clopidogrel-Treated Patien...'
Publications
- Response to Letter Regarding Article, "Proton Pump Inhibitors, Platelet Reactivity, and Cardiovascular Outcomes After Drug-Eluting Stents in Clopidogrel-Treated Patien...
- Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) trial design.
- Unplanned Inpatient and Observation Rehospitalizations After Acute Myocardial Infarction: Insights From the Treatment With Adenosine Diphosphate Receptor Inhibitors: L...
- Post-Hospital Outcomes of Patients With Acute Myocardial Infarction With Cardiogenic Shock: Findings From the NCDR.
- Going Beyond the Hard Endpoints: "Quality of Life" May Be Dependent on Quality of Available Data.
- Eligibility and utilization of implantable cardioverter-defibrillators in a regional STEMI system.
- Efficacy of a device to narrow the coronary sinus in refractory Angina.
- Increasing percutaneous Coronary interventions for ST-segment elevation myocardial infarction in the United States: progress and opportunity.
- Fibrinolysis Use Among Patients Requiring Interhospital Transfer for ST-Segment Elevation Myocardial Infarction Care: A Report From the US National Cardiovascular Data...
- Rationale and Design for PACE: Patients with Intermittent Claudication Injected with ALDH Bright Cells.
- Real-time decision support to guide percutaneous Coronary intervention bleeding avoidance strategies effectively changes practice patterns.
- Bone Marrow Characteristics Associated with Changes in Infarct Size after STEMI: A Biorepository Evaluation from the CCTRN TIME Trial.
- Volume driven performance metrics in STEMI care: Does practice make perfect?
- The impact of prolonged lower limb ischemia on amputation, mortality, and functional status: The FRIENDS registry.
- Outcomes of Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction Patients With Previous Coronary Bypass Surgery.
- Safety and Efficacy of Ixmyelocel-T: An Expanded, Autologous Multi-Cellular Therapy, in Dilated Cardiomyopathy.
- Rebuttal: Response to severe Coronary disease not amenable to revascularization-Are the series clearly defined?
- Bone marrow mononuclear cell therapy for Acute myocardial infarction: a perspective from the cardiovascular cell therapy research network.
- Satisfaction With Emergent Transfer for Percutaneous Coronary Interventions on Patients With ST-Segment-Elevation Myocardial Infarction and Their Families.
- Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting Stents: The Assessment of Dual Antiplatelet Therapy With Drug-Eluting S...
- Treatment of refractory Angina in patients not suitable for revascularization.
- Implementation of Cardovascular Cell Therapy Network trials: challenges, innovation and lessons learned from experience in the CCTRN.
- One-Year Follow-up of IntraCoronary Stem Cell Delivery on Left Ventricular Function Following ST-Elevation Myocardial Infarction.
- Emergency Medical Services as a Strategy for Improving ST-Elevation Myocardial Infarction System Treatment Times.
- New generation drug-eluting stents for ST-Elevation Myocardial infarction: A new paradigm for safety.
- Procedural variation in the performance of primary percutaneous Coronary intervention for ST-elevation myocardial infarction: A SCAI-based survey study of US intervent...
- Clinical outcomes in real-world patients with Acute myocardial infarction receiving XIENCE V(®) everolimus-eluting stents: One-year results from the XIENCE V USA study.
- Cessation of dual antiplatelet treatment and cardiac events after percutaneous Coronary intervention (PARIS): 2 year results from a prospective observational study.
- Platelet reactivity and clinical outcomes after Coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study.
- A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intraMyocardial autologous CD34+ cell a...
- Mission: Lifeline STEMI Networks Geospatial Information Systems (GIS) Maps.
- Developing an ST-elevation Myocardial infarction system of care in Dallas County.
- Long-term survival in patients with refractory Angina.
- Location, location, location! Is it important with cell delivery?
- Comparison of Functional Recovery Following Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction in Three Age Groups (<70, 70 to 79, and ≥80 Years).
- Phase II Clinical Research Design in Cardiology: Learning the Right Lessons Too Well: Observations and Recommendations From the Cardiovascular Cell Therapy Research Ne...
- Preinfarction Angina Reduces Infarct Size in ST-Elevation Myocardial Infarction Treated With Percutaneous Coronary Intervention.
- Elevated T-Wave Alternans Predicts Nonsustained Ventricular Tachycardia in Association with Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infar...
- Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after Acute myocardial infarction: the TIME randomized trial.
- Bad kidneys are bad for the Heart: But what can we do about it?
- Underuse of cardiovascular preventive pharmacotherapy in patients presenting with ST-elevation Myocardial infarction.
- How gold is the gold standard? How gold does it need to be?
- Cell tracking and the development of cell-based therapies: a view from the cardiovascular cell therapy research network.
- Electrocardiographic Differentiation of Early Repolarization From Subtle Anterior ST-Segment Elevation Myocardial Infarction.
- Effect of Transendocardial Delivery of Autologous Bone Marrow Mononuclear Cells on Functional Capacity, Left Ventricular Function, and Perfusion in Chronic Heart Failu...
- Are the Results of a Regional ST-Elevation Myocardial Infarction System Reproducible?
- Developing mechanistic insights into cardiovascular cell therapy: Cardiovascular Cell Therapy Research Network Biorepository Core Laboratory rationale.
- The prognostic role of mitral regurgitation after primary percutaneous coronary intervention for Acute ST-elevation myocardial infarction.
- Circadian Dependence of Infarct Size and Left Ventricular Function After ST Elevation Myocardial Infarction.
- The incidence and health economic burden of ischemic amputation in Minnesota, 2005-2008.
- Safety and efficacy of a pharmaco-invasive reperfusion strategy in rural ST-elevation Myocardial infarction patients with expected delays due to long-distance transfers.
- Causes of Delay and Associated Mortality in Patients Transferred With ST-Segment-Elevation Myocardial Infarction.
- Is the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell a...
- Effect of Hypoxia-Inducible Factor-1{alpha} Gene Therapy on Walking Performance in Patients With Intermittent Claudication.
- Is there a role for pre-hospital fibrinolysis in north america?
- Therapeutic Hypothermia After Out-of-Hospital Cardiac Arrest: Evaluation of a Regional System to Increase Access to Cooling.
- Cell therapy and satellite centers: the Cardiovascular Cell Therapy Research Network experience.
- Interim analysis results from the RESTORE-CLI, a randomized, double-blind multicenter phase II trial comparing expanded autologous bone marrow-derived tissue repair ce...
- A randomized, controlled, multi-center trial comparing the safety and efficacy of zotarolimus-eluting and paclitaxel-eluting stents in de novo lesions in Coronary arte...
- A randomized study of transendocardial injection of autologous bone marrow mononuclear cells and cell function analysis in ischemic Heart failure (FOCUS-HF).
- Acute coronary syndromes: from the emergency department to the catheterization laboratory-integrating evidence from recent ACS/NSTEMI trials into clinical practice: an...
- Is it time to "rescue" rescue PCI?
- Impact of age on treatment and outcomes in ST-elevation Myocardial infarction.
- Long-term follow-up of patients undergoing postconditioning during ST-elevation Myocardial infarction.
- Primary PCI in the elderly: 75 may be the new 55!
- Pharmaco-invasive strategies expand access to percutaneous Coronary intervention in ST-elevation myocardial infarction.
- ED to catheterization laboratory: a roundtable integrating trials with practice.
- Results of a phase 1, randomized, double-blind, placebo-controlled trial of bone marrow mononuclear stem cell administration in patients following ST-elevation myocard...
- Moving toward improved care for the patient with ST-elevation Myocardial infarction: a mandate for systems of care.
- Left Atrial appendage obliteration: mechanisms of healing and intracardiac integration.
- Ischemic cardiac complications following G-CSF.
- Clopidogrel pretreatment in ST-elevation myocardial infarction patients transferred for percutaneous Coronary intervention.
- Multidisciplinary standardized care for acute aortic Dissection: design and initial outcomes of a regional care model.
- Patients with Coronary artery disease not amenable to traditional revascularization: prevalence and 3-year mortality.
- Development of a network to test strategies in cardiovascular cell delivery: the NHLBI-sponsored Cardiovascular Cell Therapy Research Network (CCTRN).
- A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after Acute myocardial infarction.
- Microemboli and microvascular obstruction in Acute coronary thrombosis and sudden coronary death: relation to epicardial plaque histopathology.
- ST-elevation myocardial infarction: which patients do quality assurance programs include?
- The ideal reperfusion strategy for the ST-segment elevation myocardial infarction patient with expected delay to percutaneous Coronary intervention: paradise lost or p...
- A new option for the "no-option" patient with refractory Angina?
- More than one leg to stand on: a step forward in the management of critical limb ischemia.
- Practice variation among cardiovascular physicians in management of patients with Mitral regurgitation.
- Enhanced external counterpulsation improves systolic blood pressure in patients with refractory Angina.
- The Heart of new ulm: a vision for the future.
- Phase I cardiovascular cell therapy clinical trials: Are we running with scissors?
- Reduced-dose fibrinolytic acceleration of ST-segment elevation myocardial infarction treatment coupled with urgent percutaneous Coronary intervention compared to prima...
- "POBA Plus": will the balloon regain its luster?
- Reperfusion options in ST-elevation Myocardial infarction patients with expected delays.
- Myocardial fibrosis from severe carbon monoxide poisoning detected by cardiac magnetic resonance imaging.
- The Minneapolis Heart Institute Foundation Summer Research Internship Program: the benefits of preprofessional experience for prospective physicians.
- Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in pa...
- Comparison of outcomes in high-risk patients>70 years of age with aortic valvuloplasty and percutaneous Coronary intervention versus aortic valvuloplasty alone.
- Cell therapy for Acute myocardial infarction--where do we go from here?
- A new ELISA for use in a 3-ELISA system to assess concentrations of VEGF splice variants and VEGF(110) in ovarian cancer tumors.
- Pregnancy-associated plasma protein-A elevation in patients with Acute coronary syndrome and subsequent atorvastatin therapy.
- Emerging therapies for refractory Angina.
- "False-positive" cardiac catheterization laboratory activation among patients with suspected ST-segment elevation Myocardial infarction.
Schools
University Of California San Francisco School Of Medicine
University Co
University Mn
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Dissection
- View All
Doctors Specialties
- Cardiology
- Interventional Cardiology
Accepted Insurances
- Choice Plus POS II
- Blue Card PPO
- CaliforniaCare HMO
- Advantage Preferred DirectAccess Plus PPO
- Blue Cross Blue Shield of California PPO
- Pathway X Direct Access PPO
- Pathway X Tiered Direct Access
- Select Plus HMO
- Blue Cross Blue Shield of Illinois PPO
- Blue Cross Accord
- Access Plus Savenet
- Basic PPO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- First Health (Coventry Health Care) PPO
- Group Health Cooperative
- Covered California - Bronze PPO
- Health Net PPO
- Individual and Family PPO
- Humana
- Medica
- Medicaid
- Medicare MCR
- Kaiser PHCS Network PPO
- MultiPlan PPO
- PHCS Network PPO
- Heritage Signature
- Travelers
- Tricare
- Ucare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- PacifiCare HMO
- United Healthcare
Awards
- America's Top Doctors
- CMS Meaningful Use Stage 1 Certification
- Super Doctor
- Fellow (FACC)
Education
-
University of Minnesota at Fairview -
University of Colorado -
University of California San Francisco School of Medicine
Hospital
-
Abbott Northwestern Hospital -
Cedars-Sinai Medical Center
Drug Facts
| NPI NUMBER | 1114987997 | |
| NPPES Provider LastName | HENRY | |
| NPPES Provider FirstName | TIMOTHY | |
| NPPES Provider ZIPCode | 554073723 | |
| NPPES Provider State | MN | |
| Specialty Description | Cardiology | |
| Total Claim Count | 840.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1114987997 |
| Last Name Of The Provider | HENRY |
| First Name Of The Provider | TIMOTHY |
| View All |
Similar Doctors
|
|
Dr. Abdelwahaab S. Akef, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kevin J. Graham, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Luis A. Pagan-Carlo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Russell V. Luepker, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward O. McFalls, MD |
|
|
Dr. Allan H. Schuster, MD |
|
|
Dr. Louis P. Kohl, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ashenafi M. Tamene, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Chuen Y. Tang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Benjamin K. Johnson, MD |
|
|
Dr. Dimitrios G. Stalikas, MD |
|
|
Dr. Michelle D. Carlson, MD |
|
|
Dr. Arthur S. Leon, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|